BC Environmental and Occupational Health Research Network

The AACR-FNAB Career Development Award for Translational Cancer Research is open to junior faculty who are in the first four years of a faculty appointment (at the start of the grant term). Research projects are restricted to translational cancer research focused on any individualized therapeutic area. Proposed project must have implications for individualized cancer treatment and must make use of human biopsies or samples, such as needle biopsies or circulating cancer cells. In vivo primary tumor explants meet these criteria, but xenografts from established cell lines do not. This is a two-year grant of $100,000 ($50,000 per year) for direct research expenses and salary support.

The AACR-Conquer Cancer Foundation of ASCO Young Investigator Translational Cancer Research Award provides a one-year grant of $50,000 to support direct research expenses, which may include the salary and benefits of the grant recipient, postdoctoral or clinical research fellows and/or research assistants, research/laboratory supplies, and equipment. The purpose of this award is to fund physician-scientists during the transition from a fellowship program to a faculty appointment. The Award is open to physicians (M.D., D.O., or international equivalent) or physicians holding a combined M.D./Ph.D. Applicants must be working in an oncology laboratory or clinical research setting in an academic medical institution and be in the last two years of his/her final subspecialty training. Research projects are restricted to translational cancer research.

The AACR-FNAB Career Development Award for Translational Cancer Research is open to junior faculty who are in the first four years of a faculty appointment (at the start of the grant term). Research projects are restricted to translational cancer research focused on any individualized therapeutic area. Proposed project must have implications for individualized cancer treatment and must make use of human biopsies or samples, such as needle biopsies or circulating cancer cells. In vivo primary tumor explants meet these criteria, but xenografts from established cell lines do not. This is a two-year grant of $100,000 ($50,000 per year) for direct research expenses and salary support.

The SU2C-MRA Melanoma Dream Team Translational Cancer Research Grant will provide funding of a minimum of $6 million over a three-year period for a cancer research project that will accelerate the application of new preventive, diagnostic or therapeutic agents to the clinic. Proposals for Melanoma Dream Team projects must present plans indicating how the work will be translated into the clinic.

Independent investigators who are affiliated with any institution involved in cancer research, cancer medicine, or cancer-related biomedical science anywhere in the world may apply. There are no citizenship or geographic requirements. Applicants must have a doctoral degree (including Ph.D., M.D., D.O., D.C., N.D., D.D.S., D.V.M., Sc.D., D.N.S., Pharm.D., or equivalent doctoral degree, or a combined clinical and research doctoral degree) in a related field and not currently be a candidate for a further doctoral or professional degree.

The AACR-Aflac, Inc. Career Development Award for Pediatric Cancer Research represents a joint effort to encourage and support junior faculty who are in the first 4 years of a faculty appointment (at the start of the grant term) to conduct pediatric cancer research and establish successful career paths in this field. The research proposed for funding may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to pediatric cancer.
The Award provides $100,000 over two years ($50,000 per year) for direct research expenses, which may include salary and benefits of the grant recipient, postdoctoral or clinical research fellows, and/or research assistants, research/laboratory supplies and equipment.

The AACR Dharma Master Jiantai Innovative Grant for Lung Cancer Research will provide additional funding to an investigator for an existing project that develops and studies new ideas and approaches that have direct application and relevance to lung cancer. This support supplements existing funding for an investigator conducting a basic or translational research project that will contribute to the acceleration of progress against lung cancer, for the ultimate goal of improving patient care.

The field of cancer prevention research is rapidly advancing and evolving. To sustain the advancement of the field and the development of new thinking and strategies, younger investigators must be encouraged to pursue cancer prevention research, yet few vehicles exist to recognize their accomplishments or support their early research efforts.
This award was established and first given in 2008 to recognize the outstanding achievement of a junior faculty-level scientist, and to provide support for cancer prevention research of significant scientific merit in any discipline across the continuum of research.

The AACR Gertrude B. Elion Cancer Research Award is open to tenure-track scientists at the level of assistant professor, who completed postdoctoral studies or clinical fellowships no more than four years prior to the start of the grant term. It provides a one-year grant of $50,000 for salary and benefits, supplies, equipment, and limited travel for the grant recipient. Projects may focus on research in cancer etiology, diagnosis, treatment or prevention (basic, translational or clinical cancer research).
The recipient of the 2011 award must attend the AACR 102nd Annual Meeting 2011 to accept the award and attend the AACR 103rd Annual Meeting 2012 to give a presentation of his or her research in a minisymposium.

International research collaboration can successfully address the global health problem of cancer through access to unique populations and environments, shared resources, specialized expertise, new concepts and perspectives, innovative methodologies and/or emerging technologies. However, barriers to sustaining these collaborations exist, such as the lack of funding as well as the lack of sharing of knowledge about these important research partnerships.
This award will support highly meritorious research that is being conducted collaboratively by investigators in different countries around the world.

The Landon Foundation-AACR INNOVATOR Award for Research in Personalized Cancer Medicine represents a joint effort between the Landon Foundation and AACR to accelerate progress in the area of personalized medicine by providing support for physician-scientists who conduct meritorious studies that hold promise for near-patient benefit.
Such studies may include:
• Proof-of-concept studies in humans;
• Translational clinical trials that utilize science-based methodologies for patient selection;
• Multidisciplinary research that includes the incorporation of disciplines that are new to cancer research, i.e., the physical sciences, mathematics, etc.;
• Studies that molecularly target pathways;
• The identification of genes and genetic variations that play a role in cancer treatment responses; or
• Other innovative areas of cancer therapeutics.

The field of cancer prevention research is rapidly advancing and evolving. To sustain the advancement of the field and the development of new thinking and strategies, younger investigators must be encouraged to pursue cancer prevention research, yet few vehicles exist to recognize their accomplishments or support their early research efforts.
This Award was established and first given in 2008 to recognize the outstanding achievement of a junior faculty-level scientist, and to provide support for cancer prevention research of significant scientific merit in any discipline across the continuum of research.

The Pancreatic Cancer Action Network-AACR Innovative Grants represent a joint effort to promote and support innovative pancreatic cancer research. They aim to spur creative and cutting edge ideas and approaches in pancreatic cancer research, including those successful in other areas of cancer that have justifiable promise for pancreatic cancer. The research proposed for funding may be basic, translational, clinical or epidemiological in nature and must have direct applicability and relevance to pancreatic cancer.

The Caring for Carcinoid Foundation-AACR Grants for Carcinoid Tumor and Pancreatic Neuroendocrine Tumor Research represent a joint effort to promote and support innovative cancer research. These grants are available to independent junior and senior investigators to develop and study new ideas and approaches that have direct application and relevance to carcinoid tumors or pancreatic neuroendocrine tumors. Proposed research may be in any discipline of basic, translational, clinical, or epidemiological cancer research.

This Award was established and first given in 2008 to recognize the outstanding achievement of a junior faculty-level scientist, and to provide support for cancer prevention research of significant scientific merit in any discipline across the continuum of research. A two-year grant of $100,000 ($50,000 per year) will be provided to the recipient’s institution to support direct research expenses; salary and benefits; and attendance at an AACR Annual Meeting, Cancer Prevention Conference, or other AACR meeting for the purpose of participating in scholarly exchange.

AACR-WICR Scholar Awards are awarded to ten members of Women in Cancer Research who are scientists-in-training and presenters of meritorious scientific papers at AACR Annual Meetings.

The AACR Career Development Awards for Pediatric Cancer Research are open to junior faculty in their first full‐time faculty appointment. Proposed research projects may be in any discipline of basic, clinical, translational, or epidemiological research with direct applicability and relevance to pediatric cancer. The Awards provide a 2‐year grant of $100,000 ($50,000 per year) for direct research expenses, which may include the salary and benefits of the grant recipient, postdoctoral or clinical research fellows and/or research assistants, research/laboratory supplies, and equipment.

Proposed project must have implications for individualized cancer treatment and must make use of human biopsies or samples, such as needle biopsies or circulating cancer cells. One two-year grant of $100,000 ($50,000 per year) for direct research expenses and salary support is available.

The Pancreatic Cancer Action Network-AACR Innovative Grants represent a joint effort to promote and support innovative pancreatic cancer research. These grants are available to junior and senior investigators to develop and study new ideas and approaches that have direct application and relevance to pancreatic cancer. The research proposed for funding may be basic, translational, clinical or epidemiological in nature.
Applications are invited from researchers already involved in the field of pancreatic cancer research as well as from investigators with experience in other areas of cancer research who have promising ideas or research approaches that can be applied to pancreatic cancer.

The Breast Cancer Research Foundation-AACR Grants for Translational Breast Cancer Research were established in 2007 to provide support for innovative cancer research projects designed to accelerate the discovery, development, and application of new agents to treat breast cancer and/or for pre-clinical research with direct therapeutic intent. It is anticipated that two grants of up to $200,000 each will be awarded.